We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

WONDFO

Wondfo is a high-tech biological company focusing providing professional products and services for rapid diagnosis an... read more Featured Products: More products

Download Mobile App





Wondfo Exhibits Newly-Launched Time-Resolved Fluorescence Immunoassay Analyzers

By LabMedica International staff writers
Posted on 23 Jul 2023

Wondfo (Guangzhou, China) is providing a glimpse of its several newly-launched products alongside its flagship products at AACC 2023. More...

Wondfo's flagship products being highlighted at the show include the Finecare FIA Meters (FS-114/FS-205), Accre CLIA Analyzer (A90), and Blood Gas Analyzer (BGA-102). The Finecare FIA Meter Ⅱ Plus SE (FS-114) is intended for use by healthcare professionals to improve diagnosis and monitoring of various conditions, including COVID-19, diabetes, renal injury, cardiovascular disease, pregnancy, inflammation, tumor, etc. The Finecare FIA Meter III Plus (FS-205) is a fluorescence immunochromatographic semi-automatic analyzing system with internal temperature control. It can test 20 items at the same time and help diagnose conditions such as infection, diabetes, cardiovascular diseases, renal injury, hormone, etc.

Accre 90 is a compact automatic bench-top chemiluminescence immunoassay (CLIA) analyzer. With a single-dose reagent cartridge, it allows 600 days MTBF, requiring no extra consumables. It offers both simple operation, and a reliable calibration & quality control system. Wondfo's Blood Gas Analyzer (BGA-102) is used with its blood gas test cartridge (electrochemistry) to measure a patient's pH balance, pCO2, pO2, Na+, K+, Ca2+, Cl–, Hct, Lac, and Glu. Among its newly-launched products highlighted at AACC 2023 were the new FS-1000 and FS-2000 fluorescence immunoassay analyzers which offer improved specificity, sensitivity, repeatability, stability, and faster results in 3-8 minutes.

At the Wondfo AACC 2023 booth, Carolina Liquid Chemistries, Corp. (CLC, Greensboro, NC, USA) is showcasing the RYAN, the "next generation" of fentanyl testing. RYAN is a portable fluorescence instrument that can be used in a laboratory or point-of-care setting with the Fentanyl Urine Detection Kit which is the first ever FDA-cleared and CLIA-categorized point-of-care fentanyl test. This fluorescence immunoassay is intended for the qualitative detection of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.

Related Links:
Wondfo 
Carolina Liquid Chemistries


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.